Acorda Therapeutics Inc (NASDAQ: ACOR) is -86.81% lower on its value in year-to-date trading and has touched a low of $1.65 and a high of $24.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ACOR stock was last observed hovering at around $2.50 in the last trading session, with the day’s loss setting it -0.51%.
Currently trading at $1.99, the stock is -83.70% and -85.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.84 million and changing -20.40% at the moment leaves the stock -85.23% off its SMA200. ACOR registered -82.98% loss for a year compared to 6-month loss of -86.34%. The firm has a 50-day simple moving average (SMA 50) of $1.33 and a 200-day simple moving average (SMA200) of -$0.67.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -84.70% gain in the last 1 month and extending the period to 3 months gives it a -86.29%, and is -83.55% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 39.33% over the week and 13.72% over the month.
Acorda Therapeutics Inc (ACOR) has around 102 employees, a market worth around $2.47M and $117.63M in sales. Profit margin for the company is -214.95%. Distance from 52-week low is 20.61% and -91.78% from its 52-week high.
Acorda Therapeutics Inc quarterly earnings per share for the current quarter are estimated at $0.
23 institutions hold shares in Acorda Therapeutics Inc (ACOR), with institutional investors hold 13.31% of the company’s shares. The shares outstanding are 1.24M, and float is at 1.23M with Short Float at 0.77%. Institutions hold 13.22% of the Float.
The top institutional shareholder in the company is Davidson Kempner Partners with over 90154.0 shares valued at $1.06 million. The investor’s holdings represent 7.26% of the ACOR Shares outstanding. As of Jun 29, 2023, the second largest holder is Davidson Kempner Capital Management LP with 55145.0 shares valued at $0.72 million to account for 4.44% of the shares outstanding. The other top investors are Renaissance Technologies, LLC which holds 45561.0 shares representing 3.67% and valued at over $0.59 million, while Acadian Asset Management. LLC holds 2.75% of the shares totaling 34131.0 with a market value of $0.44 million.
